In fiscal year 2025, Hanmi Science (008930) reported revenue of 1.36 trillion KRW.
Income Statement
| Year | Revenue | Op Profit | Net Income | Source |
|---|
| 2025 | 1.36 trillion KRW | 138.7 billion KRW | 117.7 billion KRW | [source] |
| 2024 | 1.28 trillion KRW | 98.9 billion KRW | 56.7 billion KRW | [source] |
| 2023 | 1.25 trillion KRW | 124.5 billion KRW | 115.1 billion KRW | [source] |
| 2022 | 1.05 trillion KRW | 67.6 billion KRW | 69.0 billion KRW | [source] |
| 2021 | 950.2 billion KRW | 58.9 billion KRW | 42.9 billion KRW | [source] |
Balance Sheet
| Year | Total Assets | Total Liabilities | Total Equity | Source |
|---|
| 2025 | 824.4 billion KRW | 275.4 billion KRW | 549.0 billion KRW | [source] |
| 2024 | 776.1 billion KRW | 273.2 billion KRW | 502.9 billion KRW | [source] |
| 2023 | 760.9 billion KRW | 258.6 billion KRW | 502.3 billion KRW | [source] |
| 2022 | 744.3 billion KRW | 247.1 billion KRW | 497.2 billion KRW | [source] |
| 2021 | 600.6 billion KRW | 84.6 billion KRW | 516.0 billion KRW | [source] |
Cash Flow
| Year | Operating | Investing | Financing | Source |
|---|
| 2025 | — | — | — | [source] |
| 2024 | — | — | — | [source] |
| 2023 | 35.2 billion KRW | -18.7 billion KRW | -10.2 billion KRW | [source] |
| 2022 | 9.5 billion KRW | -2.1 billion KRW | -1.1 billion KRW | [source] |
| 2021 | 13.7 billion KRW | -2.2 billion KRW | -11.0 billion KRW | [source] |
Cash flow figures for the relevant year were not collected.
